Streptozotozin (STZ)-induced diabetes in mice and rats (STZ; a toxic drug that produces a destruction of pancreatic β-cells causing insulin deficiency and hyperglycemia [154]) produces increased SGLT1 intestinal expression [155]. This evidence concerns the gene SLC5A1 and Hyperglycemia.